A dominant role for FcgammaRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release.

scientific article

A dominant role for FcgammaRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1189/JLB.0805441
P698PubMed publication ID16940332
P5875ResearchGate publication ID6849084

P50authorJean S MarshallQ60329463
P2093author name stringChristine A King
Robert Anderson
Michael G Brown
Christine Sherren
P433issue6
P921main subjectmast cellQ191989
Dengue virusQ476209
P304page(s)1242-1250
P577publication date2006-08-29
P1433published inJournal of Leukocyte BiologyQ1524048
P1476titleA dominant role for FcgammaRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release
P478volume80

Reverse relations

cites work (P2860)
Q27485451Antibody-Dependent Enhancement of Hepatitis C Virus Infection
Q34171756Association of mast cell-derived VEGF and proteases in Dengue shock syndrome
Q33405382Autoimmunity in dengue pathogenesis
Q34352267Autophagy facilitates antibody-enhanced dengue virus infection in human pre-basophil/mast cells.
Q40384839Deletion of the C-terminal region of dengue virus nonstructural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency
Q27485628Dengue Virus Evolution and Virulence Models
Q40343791Dengue virus infection of mast cells triggers endothelial cell activation.
Q38158411Dengue virus infection: current concepts in immune mechanisms and lessons from murine models
Q27490922Dengue virus markers of virulence and pathogenicity
Q52689200Diverse exocytic pathways for mast cell mediators.
Q38162418Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity
Q93140606Hijacking the Host Immune Cells by Dengue Virus: Molecular Interplay of Receptors and Dengue Virus Envelope
Q91962220Insight into the Tropism of Dengue Virus in Humans
Q93077979Mast Cell Responses to Viruses and Pathogen Products
Q66679675Mast Cells in Viral, Bacterial, and Fungal Infection Immunity
Q35077675Mast cell mediator responses and their suppression by pathogenic and commensal microorganisms
Q33578155Mast cells are permissive for rhinovirus replication: potential implications for asthma exacerbations
Q40078229Plant-produced anti-dengue virus monoclonal antibodies exhibit reduced antibody-dependent enhancement of infection activity.
Q38019500Role and relevance of mast cells in fungal infections
Q24655655Role of dendritic cells in antibody-dependent enhancement of dengue virus infection
Q26777264Roles and relevance of mast cells in infection and vaccination
Q37330751Scientific consultation on cell mediated immunity (CMI) in dengue and dengue vaccine development
Q37660743Secretory phospholipase A2 in the pathogenesis of acute dengue infection
Q21144516Subversion of innate defenses by the interplay between DENV and pre-existing enhancing antibodies: TLRs signaling collapse
Q38568867Surveillance of cell and tissue perturbation by receptors in the LRC.
Q37829600The effect of bacterial, viral and fungal infection on mast cell reactivity in the allergic setting
Q58582556The monocyte-macrophage-mast cell axis in dengue pathogenesis
Q27011587Understanding the dengue viruses and progress towards their control
Q37330748Vaccine-induced enhancement of viral infections.

Search more.